Tag Archives: Biogen

Novartis touts latest Zolgensma data as SMA competition against Biogen, Roche heats up

As Roche’s new spinal muscular atrophy (SMA) drug, Evresdi, gains steam, Novartis is hoping some new trial data can help its gene therapy Zolgensma stand out in the increasingly competitive field. In phase 3 data from the SPR1NT study presented at the European Academy for Neurology virtual congress, Zolgensma met its primary and secondary goals… Read More »

Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »